NDAORALTABLETPriority Review
Approved
Dec 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
13
Data completeness
4/8 — Partial
Priority Review
BILTRICIDE (praziquantel) by Bayer. Approved for anthelmintic [epc]. First approved in 1982.
Drug data last refreshed 21h ago
Mechanism of Action
Pharmacologic Class:
Anthelmintic
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (13)
Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel
Started Jul 2025
318 enrolled
Clonorchiasis
Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis
Started Jun 2024
300 enrolled
Neurocysticercosis
Praziquantel in Children Under Age 4
Started Feb 2021
354 enrolled
SchistosomiasisSchistosomiasis MansoniSchistosoma Japonicum Infection
Bioequivalence Study of Coated Cesol Tablet Formulation Versus Biltricide
Started Jun 2020
36 enrolled
Healthy
Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study
Started Sep 2019
116 enrolled
Schistosomiasis
Worked on BILTRICIDE at Bayer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.